journal article·2023-06

Reallocating Cell Respiration Substrates for Cancer Therapy Using a Metabolism Regulator with an Intermembrane‐Translocatable Accessory

Qiu‐Yi Duan, Ya‐Xuan Zhu, Bai‐Hui Shan, Yuxin Guo, Ke‐Fei Xu, Hao‐Ran Jia, Fu‐Gen Wu

Advanced Functional Materials· Volume 33· Issue 23
Publisher page

Abstract

Abstract One hallmark of cancer cells is aberrant glucose metabolism. By desperately consuming glucose, cancer cells grow quickly and form a hypoxic core in the tumor, which severely limits the efficacy of oxygen‐dependent therapeutic strategies. Herein, a cell metabolism regulation strategy is adopted to reallocate cell respiration substrates for fueling the processes for cancer therapy by constructing a metabolism nanoregulator (denoted as ATO/GOx PLP). To be specific, a protoporphyrin IX (PpIX, the intermembrane‐translocatable accessory)‐doped liposome is employed for direct intracellular delivery of GOx and atovaquone (ATO, a mitochondrial complex III inhibitor). The PpIX‐doped liposome can efficiently avoid the cargo leakage in blood circulation. Benefiting from the translocation of PpIX from the liposome to the cancer cell membrane, ATO and GOx can be rapidly released upon encountering the plasma membrane and internalized by the cancer cell. By inhibiting mitochondrial oxidative phosphorylation and regulating mitochondrial function, ATO reduces both oxygen consumption and glucose metabolism, sparing more substrates for GOx to kill cancer cells. As a result, ATO/GOx PLP presents outstanding anticancer efficacies both in vitro and in vivo. In addition, the ATO/GOx PLP exhibits excellent biosafety, showing its clinical translation potential. Overall, this study provides a new approach to achieve efficacious metabolism regulation‐based cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Supramolecular Chemistry and Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Bioelectronics School of Biological Science and Medical Engineering Southeast University 2 Sipailou Road Nanjing Jiangsu 210096 P. R. China

Shanghai Tenth People's Hospital Shanghai Frontiers Science Center of Nanocatalytic Medicine School of Medicine Tongji University Shanghai 200331 P. R. China

The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang 310022 P. R. China

Funding

Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (62)

Show source-provided references
1. 10.1016/j.critrevonc.2017.04.00510.1016/j.critrevonc.2017.04.005 ↗
2. 10.1158/2159-8290.CD-12-034510.1158/2159-8290.CD-12-0345 ↗
3. 10.1016/j.molmet.2019.08.02110.1016/j.molmet.2019.08.021 ↗
4. 10.1016/j.lfs.2020.11860310.1016/j.lfs.2020.118603 ↗
5. 10.1021/acs.nanolett.1c0207310.1021/acs.nanolett.1c02073 ↗
6. 10.1038/nrc.2016.7710.1038/nrc.2016.77 ↗
7. 10.1085/jgp.8.6.51910.1085/jgp.8.6.519 ↗
8. 10.1021/acsami.2c0011110.1021/acsami.2c00111 ↗
9. 10.1084/jem.2012016210.1084/jem.20120162 ↗
10. 10.1016/j.cpet.2018.02.01110.1016/j.cpet.2018.02.011 ↗
11. 10.1002/adfm.20180349810.1002/adfm.201803498 ↗
12. 10.1158/0008-5472.613.65.210.1158/0008-5472.613.65.2 ↗
13. 10.1007/s12274-022-4237-210.1007/s12274-022-4237-2 ↗
14. 10.1038/s41565-021-00897-110.1038/s41565-021-00897-1 ↗
15. 10.1039/D1TB00218J10.1039/D1TB00218J ↗
16. 10.1038/s41586-022-05030-310.1038/s41586-022-05030-3 ↗
17. 10.1021/acsnano.9b0583610.1021/acsnano.9b05836 ↗
18. 10.1016/j.ccell.2022.09.00810.1016/j.ccell.2022.09.008 ↗
19. 10.1021/acsnano.6b0665810.1021/acsnano.6b06658 ↗
20. 10.1021/acs.nanolett.2c0247510.1021/acs.nanolett.2c02475 ↗
21. 10.1021/acsnano.0c0135010.1021/acsnano.0c01350 ↗
22. 10.1021/acsnano.9b1003710.1021/acsnano.9b10037 ↗
23. 10.1016/j.actbio.2022.04.02210.1016/j.actbio.2022.04.022 ↗
24. 10.1158/0008-5472.CAN-19-021710.1158/0008-5472.CAN-19-0217 ↗
25. 10.1158/0008-5472.CAN-11-012710.1158/0008-5472.CAN-11-0127 ↗
26. 10.1007/s10863-018-9755-y10.1007/s10863-018-9755-y ↗
27. 10.2147/IJN.S36484010.2147/IJN.S364840 ↗
28. 10.1039/D1NR02159A10.1039/D1NR02159A ↗
29. 10.1002/adfm.20190939110.1002/adfm.201909391 ↗
30. 10.1002/smll.20200089710.1002/smll.202000897 ↗
31. 10.1007/s40843-019-1226-810.1007/s40843-019-1226-8 ↗
32. 10.1002/advs.20210146710.1002/advs.202101467 ↗
33. 10.1039/C8MH00908B10.1039/C8MH00908B ↗
34. 10.1021/acsnano.8b0520010.1021/acsnano.8b05200 ↗
35. 10.1002/smll.20200151810.1002/smll.202001518 ↗
36. 10.1021/acsami.1c1223510.1021/acsami.1c12235 ↗
37. 10.1002/adma.20180832510.1002/adma.201808325 ↗
38. 10.1021/acsami.7b0681410.1021/acsami.7b06814 ↗
39. 10.1002/adhm.20210156310.1002/adhm.202101563 ↗
40. 10.1002/anie.20161068210.1002/anie.201610682 ↗
41. 10.1039/D0NR05501H10.1039/D0NR05501H ↗
42. 10.1002/advs.20200333810.1002/advs.202003338 ↗
43. 10.1002/anie.20210075210.1002/anie.202100752 ↗
44. 10.1002/anie.20220458410.1002/anie.202204584 ↗
45. 10.1002/anie.20191282410.1002/anie.201912824 ↗
46. 10.1002/smll.20210211310.1002/smll.202102113 ↗
47. 10.1002/adfm.20180670810.1002/adfm.201806708 ↗
48. 10.1002/adhm.20210019810.1002/adhm.202100198 ↗
49. 10.1021/acsnano.1c0802610.1021/acsnano.1c08026 ↗
50. 10.1021/acs.nanolett.0c0004710.1021/acs.nanolett.0c00047 ↗
51. 10.1002/adtp.20200001910.1002/adtp.202000019 ↗
52. 10.1021/acsnano.2c0733810.1021/acsnano.2c07338 ↗
53. 10.1126/science.108880510.1126/science.1088805 ↗
54. 10.1021/acsami.0c0911010.1021/acsami.0c09110 ↗
55. 10.1038/ncomms1230810.1038/ncomms12308 ↗
56. 10.1038/nrm.2017.13810.1038/nrm.2017.138 ↗
57. 10.1039/C7NJ00037E10.1039/C7NJ00037E ↗
58. 10.1021/acs.langmuir.6b0019310.1021/acs.langmuir.6b00193 ↗
59. 10.1016/j.colsurfb.2010.03.03210.1016/j.colsurfb.2010.03.032 ↗
60. 10.1002/cbic.20100001010.1002/cbic.201000010 ↗
61. 10.1126/sciadv.abf903310.1126/sciadv.abf9033 ↗
62. 10.1073/pnas.81.6.171510.1073/pnas.81.6.1715 ↗